» Articles » PMID: 14580223

Psychiatric Comorbidities in Children with Attention Deficit Hyperactivity Disorder: Implications for Management

Overview
Journal Paediatr Drugs
Specialties Pediatrics
Pharmacology
Date 2003 Oct 29
PMID 14580223
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Attention deficit hyperactivity disorder (ADHD) is frequently comorbid with a variety of psychiatric disorders. These include oppositional defiant disorder and conduct disorder (CD), as well as affective, anxiety, and tic disorders. ADHD and ADHD with comorbid CD appear to be distinct subtypes; children with ADHD/CD are at higher risk of antisocial personality and substance abuse as adults. Stimulants are often effective treatments for aggressive or antisocial behavior in patients with ADHD, but mood stabilizers or atypical antipsychotics may be used to treat explosive aggressive outbursts. Response to stimulants is not affected by comorbid anxiety, but children with ADHD/anxiety disorder may show greater benefit from psychosocial interventions than those with ADHD alone. The degree of prevalence of major depressive disorder (MDD) and bipolar disorder among children with ADHD is controversial, but a subgroup of severely emotionally labile ADHD children who present serious management issues for the clinician clearly exists. Antidepressants may be used in conjunction with stimulants to treat MDD, while mood stabilizers and atypical antipsychotics are often required to treat manic symptoms or aggression. After resolution of the manic episode, stimulant treatment of the comorbid ADHD may be safely undertaken. Recent research suggests that stimulants can be safely used in children with comorbid ADHD and tic disorders, but the addition of anti-tic agents to stimulants is often necessary. Clinicians who work with patients with ADHD should be prepared to deal with a wide range of emotional and behavioral problems beyond the core symptoms of inattention and impulsivity/hyperactivity.

Citing Articles

Psychiatric comorbidities of attention deficit/hyperactivity disorder in Japan: a nationwide population-based study.

Okada T, Sotodate T, Ogasawara-Shimizu M, Nishigaki N Front Psychiatry. 2024; 15:1359872.

PMID: 39512898 PMC: 11541049. DOI: 10.3389/fpsyt.2024.1359872.


The Legacy of the TTASAAN Report-Premature Conclusions and Forgotten Promises: A Review of Policy and Practice Part I.

Pavel D, Henderson T, DeBruin S Front Neurol. 2022; 12:749579.

PMID: 35450131 PMC: 9017602. DOI: 10.3389/fneur.2021.749579.


Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study.

Cutler A, Suzuki K, Starling B, Balakrishnan K, Komaroff M, Castelli M J Child Adolesc Psychopharmacol. 2022; 32(2):89-97.

PMID: 35020462 PMC: 8972004. DOI: 10.1089/cap.2021.0107.


Treatment with Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of All-Cause Poisoning in Children and Adolescents: A Self-Controlled Case Series Study.

Gao L, Man K, Chan E, Chui C, Li X, Coghill D CNS Drugs. 2021; 35(7):769-779.

PMID: 34283391 PMC: 8310501. DOI: 10.1007/s40263-021-00824-x.


Pediatric behavioral telehealth in the age of COVID-19: Brief evidence review and practice considerations.

Ros-DeMarize R, Chung P, Stewart R Curr Probl Pediatr Adolesc Health Care. 2021; 51(1):100949.

PMID: 33436319 PMC: 8049735. DOI: 10.1016/j.cppeds.2021.100949.


References
1.
Gadow K, Sverd J, Sprafkin J, Nolan E, Grossman S . Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry. 1999; 56(4):330-6. DOI: 10.1001/archpsyc.56.4.330. View

2.
Costello E, Angold A, Burns B, Stangl D, Tweed D, Erkanli A . The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psychiatry. 1996; 53(12):1129-36. DOI: 10.1001/archpsyc.1996.01830120067012. View

3.
Piacentini J, Shaffer D, Fisher P, Davies M, Gioia P . The Diagnostic Interview Schedule for Children-Revised Version (DISC-R): III. Concurrent criterion validity. J Am Acad Child Adolesc Psychiatry. 1993; 32(3):658-65. DOI: 10.1097/00004583-199305000-00025. View

4.
Murphy D, Pelham W, Lang A . Aggression in boys with attention deficit-hyperactivity disorder: methylphenidate effects on naturalistically observed aggression, response to provocation, and social information processing. J Abnorm Child Psychol. 1992; 20(5):451-66. DOI: 10.1007/BF00916809. View

5.
Arnold L, Abikoff H, Cantwell D, Conners C, Elliott G, Greenhill L . National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry. 1997; 54(9):865-70. DOI: 10.1001/archpsyc.1997.01830210113015. View